Among these proinflammatory cytokines, only S100A12, the gene encoding EN-RAGE, is substantially enhanced in the PBMCs of patients with COVID-19 patients, while its gene expression in PBMCs has been confirmed to be consistent with the protein level in plasma. This evidence concerns the gene S100A12 and COVID-19.